Page last updated: 2024-08-21

benzoxazoles and bortezomib

benzoxazoles has been researched along with bortezomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arlt, A; Ceyhan, GO; Dantes, Z; Feuerecker, B; Hassan, Z; Knauer, SK; Krämer, OH; Rad, R; Reichert, M; Saur, D; Schmid, RM; Schneeweis, C; Schneider, G; Stauber, R; Veltkamp, C; Weichert, W; Wirth, M	1

Other Studies

1 other study(ies) available for benzoxazoles and bortezomib

Article	Year
MTOR inhibitor-based combination therapies for pancreatic cancer. British journal of cancer, 2018, 02-06, Volume: 118, Issue:3 Topics: Animals; Antineoplastic Agents; Benzoxazoles; Bortezomib; Camptothecin; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyrimidines; TOR Serine-Threonine Kinases	2018

Article

Year

MTOR inhibitor-based combination therapies for pancreatic cancer.

British journal of cancer, 2018, 02-06, Volume: 118, Issue:3

Topics: Animals; Antineoplastic Agents; Benzoxazoles; Bortezomib; Camptothecin; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyrimidines; TOR Serine-Threonine Kinases

2018